QS Batterymarch Financial Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

QS Batterymarch Financial Management’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1.48M	Sell	47,500 -2,700	-5%	-$73.1K	0.04%	466
2014 Q2	$1.3M	Sell	50,200 -2,700	-5%	-$60K	0.03%	490
2014 Q1	$1.24M	Hold	52,900	–	–	0.03%	614
2013 Q4	$1.34M	Sell	52,900 -400	-0.8%	-$9.03K	0.03%	573
2013 Q3	$1.09M	Buy	+53,300	New	+$1.19M	0.02%	608

Other funds holding SGNT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

QS Batterymarch Financial Management's SGNT Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) stake by 5.4% in Q3 2014, selling an estimated $73.1K and leaving 47,500 shares worth $1.48M. The position accounts for 0.04% of the portfolio, ranked #466.

QS Batterymarch Financial Management first reported a position in SGNT in Q3 2013 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold SGNT as of Q3 2014.

QS Batterymarch Financial Management held 47,500 shares of SAGENT PHARMACEUTICALS INC COM STK (DE) worth $1.48M as of Q3 2014.
QS Batterymarch Financial Management sold 2,700 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $73.1K.
SAGENT PHARMACEUTICALS INC COM STK (DE) made up 0.04% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #466 holding.
QS Batterymarch Financial Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and has held it in 5 quarters since.
114 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.